SXTC

Conviction 24Scan · Wed, Oct 7, 2026

China SXT Pharmaceuticals, Inc. (SXTC) closed at $2.85 (+128.00%) on Oct 7, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 35, RS Rating 1, -100.0% from its 52-week high, -100.0% year to date. Sector: Pharmaceutical Preparations.

SXTC$2.85+128.00%

ResistanceSupportVol 14

Vol MA14 9.27M

Jul 10Jul 28Aug 14Sep 1Sep 21Oct 7

China SXT Pharmaceuticals, Inc.Pharmaceutical Preparationswww.sxtchina.com ↗

Price2.85

Change+128.00%

Gap+156.40%

Rel volume83.24×

Avg volume7.24M

Avg $ vol19.59M

SMA 202.45

SMA 503.32

SMA 200982.19

Price vs 50-14.07%

Price vs 200-99.71%

MA stackbearish

50/200 cross—

Supertrenddown · 3.76

RSI (14)35

MACD hist1.33

MACD cross—

Stoch %K / %D20 / 18

ADX (14)37

+DI / −DI40 / 26

RSI divergence—

MACD divergenceBearish

ATR %63.68%

ADR %32.05%

52w high16,000.00

52w low1.25

From 52w high-99.98%

Above 52w low+128.00%

New 52w highNo

SqueezeOn · 27d

Bollinger width62.12%

%B0.77

Donchian pos19.95%

Donchian high9.55

Donchian low1.18

AVWAP (52w high)7.49

vs AVWAP high-61.95%

AVWAP (52w low)4.51

vs AVWAP low-36.83%

OBV trendUp

Chaikin MF (20)-0.65

Today vs 20d83.24×

Avg vol (14d)9.27M

Avg vol (20d)7.24M

Avg $ vol (20d)19.59M

Market cap—

RS Rating1 / 99

RS 3m (vs SPY)-101.98%

RS 6m (vs SPY)-113.38%

RS line new highNo

Trend template1/8

Technical rank23.6

1 week-5.32%

1 month+27.23%

3 months-98.59%

6 months-98.42%

1 year-99.98%

YTD-99.98%

P/E—

P/B0.18

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.02

Current7.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-22.09M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out38.22M

Employees75

ListedFri, Jan 4, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction24 / 100

Pattern quality—

Tech rank23.6 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.41

Support1.92

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in SXTC

All disclosures →

No recent disclosed trades by Congress in SXTC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SXTC

No recent insider (Form 4) filings in SXTC. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SXTC · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.